Vetr Inc. disclosed Johnson & Johnson (NYSE:JNJ), boosting its price target to $123.14 earlier today
- Updated: September 30, 2016
Having a price of $117.27, Johnson & Johnson (NYSE:JNJ) traded 0.73% higher on the day. With the last stock price up 1.26% from the two hundred day average, compared with the Standard & Poor's 500 Index which has decreased -0.01% over the same period. JNJ has recorded a 50-day average of $119.23 and a two hundred day average of $116.66. Trade Volume was up over the average, with 7,941,065 shares of JNJ changing hands over the typical 6,259,060
Reporting a potential upside of 0.05%, Vetr Inc. upped the price target of Johnson & Johnson (NYSE:JNJ) to $123.14
Recent Performance Chart
Johnson & Johnson has PE ratio of 22.01 with a one year low of $92.58 and a one year high of $126.07 and has a market capitalization of $0.
A total of 18 brokerages have issued a ratings update on Johnson & Johnson. zero brokerages rating the company a strong buy, zero brokerages rating the company a buy, zero brokerages rating the company a hold, zero brokerages rating the company a underperform, and finally zero brokerages rating the company a sell with a 12-month price target of $117.44.
General Company Details For Johnson & Johnson (NYSE:JNJ)
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company's segments include Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on over five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.